C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track Platform for Drug Product Manufacturing

Tuesday, June 30, 2020

Ajinomoto BioPharma Services a leading provider of biopharmaceutical contract development and manufacturing services is pleased to announce the launch of AJILITY a flexible and agile drug product manufacturing platform designed to advance vaccines an...

Completion of Biotech Packaging Center of Excellence in Philadelphia & Expansions in Europe

Monday, June 29, 2020

PCI Pharma Services today announced the completion of the expansion of its new Biotech Packaging Center of Excellence in Philadelphia Pennsylvania a major investment that will represent the new US biologics flagship site for customers

Avantor® Expands Life Sciences Innovation Center to Address Bioprocessing Needs in Protein Science, Monoclonal Antibodies (mAbs), Cell and Gene Therapy

Tuesday, June 30, 2020

Avantor Inc a leading global provider of missioncritical products and services to customers in the life sciences a dvanced technologies and a pplied materials industries today announced the expansion of the companys Bridgewater NJ USA innovation ce...

European Commission Approves DAURISMO™ (glasdegib) for Certain Adult Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Tuesday, June 30, 2020

Pfizer Inc announced that the European Commission approved DAURISMO glasdegib a Hedgehog pathway inhibitor in combination with lowdose cytarabine LDAC a type of chemotherapy for the treatment of newly diagnosed de novo or secondary acute myeloid leuk...

FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Tuesday, June 30, 2020

EMD Serono the biopharmaceutical business of Merck KGaA Darmstadt Germany in the US and Canada and Pfizer Inc announced that the US Food and Drug Administration FDA has approved the supplemental Biologics License Application sBLA for BAVENCIO aveluma...

Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1

Tuesday, June 30, 2020

AstraZeneca today announced that selumetinib has been granted orphan drug designation ODD in Japan for the treatment of neurofibromatosis type NF a rare and debilitating genetic disease

Oncomine Precision Assay receives breakthrough device designation by the U.S FDA

Tuesday, June 30, 2020

Thermo Fisher Scientific the world leader in serving science received breakthrough device designation for its Oncomine Precision Assay by the US Food and Drug Administration FDA The assay can be used to identify lowgrade glioma LGG patients with isoc...

Allmpus Laboratories Embraces Local Manufacturing of Pharmaceutical Essentials

Tuesday, June 30, 2020

Allmpus Laboratories one of Indias leading researchbased pharmaceutical enterprise is turning to local manufacturing for Pharma essentials The initiative is taken to localise supply networks and reduce dependency on other countries for raw materials...

US FDA Grants Orphan Drug Designation (ODD) for Prestige BioPharma’s PBP1510 Anti-PAUF Monoclonal Antibody for the Treatment of Pancreatic Cancer

Tuesday, June 30, 2020

Prestige BioPharma Ltd hereinafter Prestige BioPharma today announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to its firstinclass antiPAUF monoclonal antibody PBP for the treatment of pancreatic cancer

FDA approves Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancer

Tuesday, June 30, 2020

Roche announced that the US Food and Drug Administration FDA has approved Phesgo a fixeddose combination of Perjeta pertuzumab and Herceptin trastuzumab with hyaluronidase administered by subcutaneous SC under the skin injection in combination with i...